HopeStage
Back to all studies
CompletedNCT02374996

Pharmacoepigenetics of Bipolarity Treatment

Observational studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
DetroitSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNovember 2015
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Wayne State University
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02374996
Official title
Show the full official title

Pharmacoepigenetics of Second Generation Antipsychotic-Induced Insulin Resistance in Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Detroit

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wayne State University, a university.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies